AbbVie | ABBV - Frais De Vente Et D'Administration

Prix De L'Action
219.68
Variation Quotidienne
-5.69 -2.52%
Mensuellement
-5.66%
Annuel
3.74%
Q1 Prévisions
213.05




Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.89B 325M 2025-12
Abbott USD 3.13B 125M 2025-12
ALKERMES USD 187.2M 15.43M 2025-12
Amgen USD 1.94B 237M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Coherus Biosciences USD 26.02M 8.57M 2025-03
Eisai JPY 111.72B 7.86B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
J&J USD 6.75B 831M 2025-12
Medtronic 2.97B 159M 2025-09
Merck USD 2.85B 215M 2025-12
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
Novartis USD 3.31B 134M 2025-09
Pacira USD 91.87M 70K 2025-12
Perrigo USD 255.9M 10.2M 2025-12
Pfizer USD 4.08B 894M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.75B 455M 2025-12
UCB EUR 1.29B 221M 2024-12
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
United Therapeutics USD 190.6M 38.6M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Zoetis USD 619M 40M 2025-12